Abstract
BackgroundThe aim of this study was to compare the topical to IV tranexamic acid (TXA) administration of the same dose, given at the same time in patients who underwent TKR using an enhanced recovery after surgery (ERAS) regime. MethodsNinety patients were randomized in control group, and IV and topical application groups received 1g TXA. ResultsBlood loss and transfusion requirements in control group were statistically higher compared to both TXA groups (p<0.05). Length of stay was the same in all groups. ConclusionsTXA reduced significantly the blood loss and the need for transfusion in ERAS primary unilateral TKR.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
